What's Going On With Viking Therapeutics Stock On Wednesday?
On Wednesday, Merck & Co Inc (NYSE:MRK) and Hansoh Pharma, a Chinese biopharmaceutical company, entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral sma
Pharma’s data and analytics market forecast to reach to $2.1bn by 2028
A new report identifies data content management as the primary driver of growth in the pharmaceuticals market.
Top Stock Movers Now: Jabil, Nvidia, General Mills, and More
U.S. equities gained at midday ahead of what's expected to be the announcement of another interest-rate cut from the Federal Reserve.
Here’s Why the Dow Just Had Its Worst Slump in 50 Years
The Dow Jones Industrial Average is riding its longest stretch of consecutive daily losses since 1974. Healthcare controversy and the peculiar way the index is calculated lie behind the slump.
Nvidia stock pops 3% after slumping into correction territory
Nvidia (NVDA) stock climbed during Wednesday morning trading after slumping into correction territory earlier in the week.
Oklo Stock Jumps, Retreats in Whipsaw Trading After Switch Announcement
Oklo, a nuclear energy startup, announced a partnership on Wednesday with Switch, a data center provider that works in the cloud and artificial intelligence industries. The stock swung wildly as inves
Jabil Stock Soars on Circuit Board Maker's Q1 Results, Raised Outlook
Jabil exceeded profit and sales estimates in the first quarter since announcing a restructuring.
Nissan Stock Jumps as Investors Eye Possibility of Honda Deal
Honda and Nissan have acknowledged the possibility of a merger, driving an active trading session in Tokyo for the Japanese auto makers.
Buffett Favorite Heico Stock Sinks as Electronic Technologies Sales Slip
Heico set records for revenue, net income, and operating income in the fourth quarter, but overall sales missed estimates, sending shares lower.
General Mills Stock Slips as Cereal Maker Lowers Full-Year Profit Outlook
General Mills shares moved lower Wednesday morning as the company's lowered fiscal 2025 profit outlook offset second-quarter results that beat analysts' estimates.